Elypta, the Swedish molecular diagnostics firm pioneering metabolism-based liquid biopsies, has raised €6.1 million in a late seed funding round closing in December 2019 and led by Industrifonden and Sciety. Norrsken Foundation's newly raised impact fund also contributed. Other investors included Barcelona-based seed fund Nina Capital and Chalmers Ventures, an owner since … [Read more...] about Elypta, the Swedish molecular diagnostics firm, raises €6 Million in a Late Seed Round
molecular diagnostics
Inflammatix Announces $32 Million in Series C Funding
Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, today announced a $32 million Series C financing. The funding round included participation from existing investors Khosla Ventures, Northpond Ventures and Think.Health Ventures, and new investors that include Grey Sky Venture Partners. The funds will be used to advance … [Read more...] about Inflammatix Announces $32 Million in Series C Funding